揭示COOL-AF评分在不同人群中的潜力：外部验证的见解 - Suppr

Suppr

超能文献

Unveiling the Potential of COOL-AF Scores in Diverse Populations: Insights From External Validation.

作者信息

Li Mingfang

机构信息

Division of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.

出版信息

JACC Asia. 2024 Jan 2;4(1):70-72. doi: 10.1016/j.jacasi.2023.11.002. eCollection 2024 Jan.

DOI:10.1016/j.jacasi.2023.11.002

PMID:39233791

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11371545/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b36a/11371545/c7ce6b570d96/ga1.jpg

相似文献

Unveiling the Potential of COOL-AF Scores in Diverse Populations: Insights From External Validation.揭示COOL-AF评分在不同人群中的潜力：外部验证的见解

JACC Asia. 2024 Jan 2;4(1):70-72. doi: 10.1016/j.jacasi.2023.11.002. eCollection 2024 Jan.

External Validation of COOL-AF Scores in the Asian Pacific Heart Rhythm Society Atrial Fibrillation Registry.亚太心律学会心房颤动注册研究中COOL-AF评分的外部验证

JACC Asia. 2023 Nov 14;4(1):59-69. doi: 10.1016/j.jacasi.2023.09.011. eCollection 2024 Jan.

Improving risk prediction for death, stroke and bleeding in Asian patients with atrial fibrillation.改善亚洲房颤患者的死亡、卒中和出血风险预测。

Eur J Clin Invest. 2023 Feb;53(2):e13886. doi: 10.1111/eci.13886. Epub 2022 Oct 17.

Stroke and bleeding risk scores in patients with atrial fibrillation and valvular heart disease: evaluating 'valvular heart disease' in a nationwide cohort study.心房颤动和心脏瓣膜病患者的卒中与出血风险评分：在全国范围内队列研究中评估“心脏瓣膜病”。

Europace. 2019 Jan 1;21(1):33-40. doi: 10.1093/europace/euy151.

Risk factors for thromboembolic and bleeding events in anticoagulated patients with atrial fibrillation: the prospective, multicentre observational PREvention oF thromboembolic events - European Registry in Atrial Fibrillation (PREFER in AF).心房颤动抗凝治疗患者血栓栓塞和出血事件的风险因素：前瞻性、多中心观察性预防血栓栓塞事件-心房颤动欧洲登记研究（PREFER in AF）。

BMJ Open. 2019 Mar 30;9(3):e022478. doi: 10.1136/bmjopen-2018-022478.

Comparative validation of HAS-BLED, GARFIELD-AF and ORBIT bleeding risk scores in Asian people with atrial fibrillation treated with oral anticoagulant: A report from the COOL-AF registry.亚洲口服抗凝药物治疗的心房颤动患者中 HAS-BLED、GARFIELD-AF 和 ORBIT 出血风险评分的比较验证：来自 COOL-AF 登记处的报告。

Br J Clin Pharmacol. 2023 Aug;89(8):2472-2482. doi: 10.1111/bcp.15716. Epub 2023 Apr 4.

Bleeding Risk Scores in Atrial Fibrillation and Venous Thromboembolism.心房颤动和静脉血栓栓塞的出血风险评分

Am J Cardiol. 2017 Oct 1;120(7):1139-1145. doi: 10.1016/j.amjcard.2017.06.058. Epub 2017 Jul 14.

The ORBIT bleeding score: a simple bedside score to assess bleeding risk in atrial fibrillation.ORBIT出血评分：一种用于评估房颤出血风险的简单床旁评分。

Eur Heart J. 2015 Dec 7;36(46):3258-64. doi: 10.1093/eurheartj/ehv476. Epub 2015 Sep 29.

Improved risk stratification of patients with atrial fibrillation: an integrated GARFIELD-AF tool for the prediction of mortality, stroke and bleed in patients with and without anticoagulation.改善房颤患者的风险分层：用于预测抗凝和未抗凝患者的死亡率、卒中和出血的 GARFIELD-AF 综合工具。

BMJ Open. 2017 Dec 21;7(12):e017157. doi: 10.1136/bmjopen-2017-017157.

Stroke and major bleeding risk in elderly patients aged ≥75 years with atrial fibrillation: the Loire Valley atrial fibrillation project.≥75岁老年心房颤动患者的卒中与大出血风险：卢瓦尔河谷心房颤动项目

Stroke. 2015 Jan;46(1):143-50. doi: 10.1161/STROKEAHA.114.007199. Epub 2014 Nov 25.

本文引用的文献

External Validation of COOL-AF Scores in the Asian Pacific Heart Rhythm Society Atrial Fibrillation Registry.亚太心律学会心房颤动注册研究中COOL-AF评分的外部验证

JACC Asia. 2023 Nov 14;4(1):59-69. doi: 10.1016/j.jacasi.2023.09.011. eCollection 2024 Jan.

Improving risk prediction for death, stroke and bleeding in Asian patients with atrial fibrillation.改善亚洲房颤患者的死亡、卒中和出血风险预测。

Eur J Clin Invest. 2023 Feb;53(2):e13886. doi: 10.1111/eci.13886. Epub 2022 Oct 17.

2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC.2020年欧洲心脏病学会（ESC）与欧洲心胸外科学会（EACTS）合作制定的心房颤动诊断和管理指南：欧洲心脏病学会（ESC）心房颤动诊断和管理特别工作组，由ESC欧洲心律协会（EHRA）特别贡献制定。

Eur Heart J. 2021 Feb 1;42(5):373-498. doi: 10.1093/eurheartj/ehaa612.

Antithrombotic Therapy for Atrial Fibrillation: CHEST Guideline and Expert Panel Report.抗栓治疗心房颤动：CHEST 指南和专家报告。

Chest. 2018 Nov;154(5):1121-1201. doi: 10.1016/j.chest.2018.07.040. Epub 2018 Aug 22.

Stroke Prevention in Atrial Fibrillation: Focus on Asian Patients.心房颤动的卒中预防：聚焦亚洲患者。

Korean Circ J. 2018 Aug;48(8):665-684. doi: 10.4070/kcj.2018.0190.

Major bleeding and intracranial hemorrhage risk prediction in patients with atrial fibrillation: Attention to modifiable bleeding risk factors or use of a bleeding risk stratification score? A nationwide cohort study.心房颤动患者的大出血和颅内出血风险预测：关注可改变的出血风险因素还是使用出血风险分层评分？一项全国性队列研究。

Int J Cardiol. 2018 Mar 1;254:157-161. doi: 10.1016/j.ijcard.2017.11.025. Epub 2018 Jan 28.

The ABC pathway: an integrated approach to improve AF management.ABC路径：改善房颤管理的综合方法。

Nat Rev Cardiol. 2017 Nov;14(11):627-628. doi: 10.1038/nrcardio.2017.153. Epub 2017 Sep 29.

CHADS-VASc Score for Identifying Truly Low-Risk Atrial Fibrillation for Stroke: A Korean Nationwide Cohort Study.用于识别真正低风险房颤卒中的CHADS-VASc评分：一项韩国全国性队列研究

Stroke. 2017 Nov;48(11):2984-2990. doi: 10.1161/STROKEAHA.117.018551. Epub 2017 Sep 22.

Risk of Ischemic Stroke in Patients With Non-Valvular Atrial Fibrillation Not Receiving Oral Anticoagulants　- Korean Nationwide Population-Based Study.未接受口服抗凝剂治疗的非瓣膜性心房颤动患者发生缺血性卒中的风险——韩国全国基于人群的研究

Circ J. 2017 Jul 25;81(8):1158-1164. doi: 10.1253/circj.CJ-16-1267. Epub 2017 Apr 12.

Comparisons of CHADS2 and CHA2DS2-VASc scores for stroke risk stratification in atrial fibrillation: Which scoring system should be used for Asians?用于心房颤动中风风险分层的CHADS2和CHA2DS2-VASc评分比较：亚洲人应使用哪种评分系统？

Heart Rhythm. 2016 Jan;13(1):46-53. doi: 10.1016/j.hrthm.2015.08.017. Epub 2015 Aug 12.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验